 |
市場調查報告書
商品編碼
1699444
全球抗組織胺市場：依藥物類別、劑型、適應症、給藥途徑、類型、分銷管道和地區Global Antihistamine Drugs Market, By Drug Class, By Form, By Indication, By Route of Administration, By Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2025年全球抗組織胺市場規模為 1,017.4億美元，到2032年將達到 1,678億美元，2025-2032年的年複合成長率為 7.4%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 1017.4億美元 |
| 歷史資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年年複合成長率： | 7.40% | 2032年價值預測 | 1678億美元 |
圖表.全球市場佔有率（依地區）（2025年）
抗組織胺是一種用於治療打噴嚏、發癢、流鼻水和流淚等過敏症狀的藥物。這些藥物透過阻斷組織胺（人體在過敏反應過程中釋放的一種物質）的作用而發揮作用。抗組織胺藥物主要有兩種：第一代抗組織胺和第二代抗組織胺。抗組織胺可透過櫃檯購買，也可透過處方購買，其種類和強度各不相同。它有多種形式，包括錠劑、膠囊、液體、滴鼻劑和眼藥水。
市場動態：
由於過敏症盛行率上升、新產品推出以及創新配方的核准，預計抗組織胺市場在預測期內將顯著成長。例如，2021年 6月，美國食品藥物管理局透過稱為部分處方藥到非處方藥轉換的流程核准了一種非處方鼻用抗組織胺。美國FDA核准Astepro（鹽酸氮卓斯汀鼻噴霧，0.15%）用於治療6歲及以上成人和兒童的季節性和常年性過敏性鼻炎（也稱為過敏症）。
本研究的主要特點
- 本報告對全球抗組織胺市場進行了詳細分析，並以2024年為基準年，展示了預測期（2025-2032年）的市場規模和年複合成長率。
- 強調了不同領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
- 提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 全球抗組織胺市場的主要企業根據以下參數進行分析，例如公司亮點、產品系列、主要亮點、績效和策略。
- 研究包括的主要企業包括Bayer AG、Almirall, S.A.、GlaxoSmithKline、Johnson and Johnson、Sanofi、Pfizer Inc.、Sun Pharmaceutical Industries Limited、Merck &Co.、Teva Pharmaceutical Industries Ltd.、Abbott Laboratories、Viatris Inc.、Arlak Biotech、Aden Healthcare、Sandoz Group AG、Hikma Pharmaceuticals PLC、Dr. Reddy's Laboratories、Cipla。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。
- 全球抗組織胺藥物市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員可以透過用於分析全球抗組織胺市場的各種策略矩陣來促進決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
第2章 市場概述
- 報告描述
- 市場定義和範圍
- 執行摘要
- 市場機會藍圖
第3章 關鍵見解
- 市場動態
- 促進因素
- 限制因素
- 機會
- 影響分析
- PEST分析
- 波特分析
- 技術進步
- 合併、收購和合作場景
- 近期產品核可
- 公司市場佔有率分析
- 確定每個地區的主要企業
- 進出口分析
- 監管情景
- 定價分析
- 產品召回
第4章 2020年至2032年全球抗組織胺市場（依藥物類別）
- H-1抗組織胺藥
- 第一代
- 第二代
- H-2抗組織胺藥
第5章 全球抗組織胺市場（依形式），2020年至2032年
- 液體
- 藥片
- 膠囊
- 凝膠
- 鼻噴劑
- 其他
第6章 全球抗組織胺市場（依適應症），2020年至2032年
- 過敏性疾病
- 胃腸道疾病
- 中樞神經系統疾病
- 皮膚病
- 其他
第7章 全球抗組織胺市場（依給藥途徑），2020年至2032年
- 口服
- 腸外
- 其他
第8章 2020年至2032年全球抗組織胺市場（依類型）
- 非處方藥
- 處方箋
第9章 全球抗組織胺市場（依通路），2020-2032年
- 醫院藥房
- 網路藥局
- 零售藥局
第10章 2020年至2032年全球抗組織胺市場（依地區）
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東
- 非洲
第11章 公司簡介-全球抗組織胺市場
- GlaxoSmithKline
- 公司簡介
- 產品/服務組合
- 財務表現
- 最新動態/更新
- 策略概述
- Bayer AG
- Almirall SA
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck &Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories
- Cipla
第12章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI6700
Global Antihistamine Drugs Market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 101.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.40% | 2032 Value Projection: | USD 167.80 Bn |
Figure. Global Antihistamine Drugs Market Share (%), By Region 2025
Antihistamine drugs are a class of medications that are used to treat symptoms of allergies, such as sneezing, itching, runny nose, and watery eyes. These drugs work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. There are two main types of antihistamines: First-generation antihistamines and second-generation antihistamine. Antihistamines are available over-the-counter and by prescription, depending on the specific medication and its strength. They come in various forms, including tablets, capsules, liquids, nasal sprays, and eye drops.
Market Dynamics:
The antihistamine drugs market is expected to witness significant growth over the forecast period owing to rise in the prevalence of allergies coupled, new product launches and approvals of innovative formulations. For instance, in June 2021, the U.S. Food and Drug Administration approved a nasal antihistamine for nonprescription use through a process known as a partial prescription to nonprescription switch. The U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis (also known as allergies) in adults and children aged six and older.
Key Features of the Study:
- This report provides an in-depth analysis of the global antihistamine drugs market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antihistamine drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Bayer AG, Almirall, S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antihistamine drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antihistamine drugs market
Detailed Segmentation:
- By Drug Class:
- H-1 Antihistamines
- First-generation
- Second-generation
- H-2 Antihistamines
- By Form:
- Liquid
- Tablets
- Capsules
- Gels
- Nasal Sprays
- Others
- By Indication:
- Allergic Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Dermatological Disorders
- Others
- By Route of Administration:
- Oral
- Parenteral
- Others
- By Type:
- OTC
- Prescription
- By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Bayer AG
- Almirall S.A
- GlaxoSmithKline
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories
- Cipla
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Form
- Market Snapshot, By Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
- Market Opportunity Map
3. Key Insights
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancements
- Merger, Acquisition, and Collaboration Scenario
- Recent Product Approvals
- Company Market Share Analysis
- Identification of Key Players in Each Region
- Import-Export Analysis
- Regulatory Scenario
- Pricing Analysis
- Product Recalls
4. Global Antihistamine Drugs Market, By Drug Class, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- H-1 Antihistamines , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- First-generation, 2020 - 2032(US$ Billion)
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Second-generation, 2020 - 2032(US$ Billion)
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- H-2 Antihistamines , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
5. Global Antihistamine Drugs Market, By Form, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Liquid, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Tablets, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Capsules, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Gels, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Nasal Sprays, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
6. Global Antihistamine Drugs Market, By Indication, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Allergic Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Gastrointestinal Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Central Nervous System Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Dermatological Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
7. Global Antihistamine Drugs Market, By Route of Administration, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Oral, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Parenteral, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
8. Global Antihistamine Drugs Market, By Type, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- OTC, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Prescription, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
9. Global Antihistamine Drugs Market, By Distribution Channel, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Hospital Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Online Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Retail Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
10. Global Antihistamine Drugs Market, By Region, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- Asean
- Rest Of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest Of The Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
- South Africa
- North Africa
- Central Africa
11. Company Profiles - Global Antihistamine Drugs Market
- GlaxoSmithKline *
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Bayer AG
- Almirall S.A
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories
- Cipla
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
過敏性鼻炎市場規模、佔有率及成長分析（按類型、治療、給藥途徑、劑型、檢測方法、分銷管道和地區）－2025-2032 年產業預測
過敏性鼻炎藥物市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測過敏性鼻炎治療市場：依治療類型、給藥途徑、通路及地區分類馬來酸氯苯那敏市場機會、成長動力、產業趨勢分析與預測 2025 - 2034
減充血劑市場：按類型、類別、適應症、分銷管道分類 – 2025-2030 年全球預測過敏性鼻炎治療藥物市場：按給藥途徑、藥物類別和應用分類 - 全球預測 2025-2030抗組織胺市場：按藥物類型、給藥途徑、治療疾病、最終用戶、劑型分類 - 全球預測 2025-2030氯苯並沙明市場：按應用、形式、分銷管道、最終用戶、產品類型分類 - 2025-2030 年全球預測
全球過敏性鼻炎藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測過敏性鼻炎治療藥物市場：2024-2034
▼